Sleep disturbances in patients with chronic pain: Effectively managing opioid analgesia to improve outcomes

Current Medical Research and Opinion

Volumn 25, Issue 5, 2009, Pages 1045-1055

  Brennan, Michael J ^a,b   Lieberman III, Joseph A ^c  

^a The Pain Center of Fairfield   (United States)

^b BRIDGEPORT HOSPITAL   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Chronic pain; Morphine; Opioid analgesics; Sleep

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; DEXTROPROPOXYPHENE; FENTANYL; GABAPENTIN; HYDROCODONE; HYDROMORPHONE; IBUPROFEN; METHADONE; MORPHINE; MORPHINE SULFATE; OPANA ER; OPIATE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; OXYMORPHONE; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRAZODONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; ZOLPIDEM;

ACTIMETRY; ANALGESIA; CHRONIC PAIN; CLINICAL TRIAL; DISEASE ASSOCIATION; HUMAN; LOW BACK PAIN; NONREM SLEEP; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP TIME;

ANALGESIA; ANALGESICS, OPIOID; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; HUMANS; PAIN; SLEEP; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 67649390896     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990902797790     Document Type: Review

References (65)

1. Onen SH, Onen F, Courpron P, et al. How pain and analgesics disturb sleep. Clin J Pain 2005;21:422-431 (Pubitemid 41233137)
2. Moldofsky H, Scarisbrick P, England R, et al. Musculoskeletal symptoms and non-REM sleep disturbance in patients with 'fibrositis syndrome' and healthy subjects. Psychosom Med 1975;37:341-351
3. Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976;38:35-44
4. Tang NK, Wright KJ, Salkovskis PM. Prevalence and correlates of clinical insomnia co-occurring with chronic back pain. J Sleep Res 2007;16:85-95 (Pubitemid 46272555)
5. Edwards RR, Almeida DM, Klick B, et al. Duration of sleep contributes to next-day pain report in the general population. Pain 2008;137:202-207
6. Gupta A, Silman AJ, Ray D, et al. The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology 2007;46:666-671 (Pubitemid 46523314)
7. Rosenthal M, Moore P, Groves E, et al. Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA®): Findings from a pilot study. J Opioid Manag 2007;3:145-154 (Pubitemid 47244097)
8. Dworkin RH, Corbin AE, Young Jr JP, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003;60:1274-1283 (Pubitemid 36460982)
9. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280:1837-1842 (Pubitemid 28544424)
10. Gore M, Brandenburg NA, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 2005;30:374-385 (Pubitemid 41527124)
11. Zelman DC, Brandenburg NA, Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 2006;22:681-685 (Pubitemid 44434950)
12. Gustorff B, Dorner T, Likar R, et al. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiol Scand 2008;52:132-136
13. Meyer-Rosberg K, Kvarnstrom A, Kinnman E, et al. Peripheral neuropathic pain - a multidimensional burden for patients. Eur J Pain 2001;5:379-389 (Pubitemid 34072465)
14. Goldenberg DL. Fibromyalgia and its relation to chronic fatigue syndrome, viral illness and immune abnormalities. J Rheumatol Suppl 1989;19:91-93 (Pubitemid 20015399)
15. Hawker GA, Stewart L, French MR, et al. Understanding the pain experience in hip and knee osteoarthritis - an OARSI/ OMERACT initiative. Osteoarthr Cartil 2008;16:415-422
16. Morriss RK, Wearden AJ, Battersby L. The relation of sleep difficulties to fatigue, mood and disability in chronic fatigue syndrome. J Psychosom Res 1997;42:597-605 (Pubitemid 27299954)
17. Treharne GJ, Lyons AC, Hale ED, et al. Sleep disruption frequency in rheumatoid arthritis: perceived stress predicts poor outcome over one year. Musculoskeletal Care 2007;5:51-64
18. Lavie P, Nahir M, Lorber M, et al. Nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis patients. Lack of association between clinical improvement and effects on sleep. Arthritis Rheum 1991;34:655-659
19. Nicassio PM, Wallston KA. Longitudinal relationships among pain, sleep problems, and depression in rheumatoid arthritis. J Abnorm Psychol 1992;101:514-520
20. McCracken LM, Iverson GL. Disrupted sleep patterns and daily functioning in patients with chronic pain. Pain Res Manag 2002;7:75-79 (Pubitemid 35056116)
21. Menefee LA, Frank ED, Doghramji K, et al. Self-reported sleep quality and quality of life for individuals with chronic pain conditions. Clin J Pain 2000;16:290-297 (Pubitemid 32046982)
22. Smith MT, Perlis ML, Smith MS, et al. Sleep quality and presleep arousal in chronic pain. J Behav Med 2000;23:1-13 (Pubitemid 30164132)
23. Morin CM, Gibson D, Wade J. Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 1998;14:311-314 (Pubitemid 28560153)
24. American Psychiatric Association. Sleep disorders. In: Diagnostic and Statistical Manual of Mental Disorders: Diagnostic Criteria for Primary Insomnia, 4th edn, Text Revision. Washington, DC: American Psychiatric Association, 2000:597-661
25. Ohayon MM. Relationship between chronic painful physical condition and insomnia. J Psychiatr Res 2005;39:151-159 (Pubitemid 39602639)
26. Fulda S, Schulz H. Cognitive dysfunction in sleep disorders. Sleep Med Rev 2001;5:423-445 (Pubitemid 34066249)
27. Turk DC, Dworkin RH, Revicki D, et al. Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain. Pain 2008;137:276-285 (Pubitemid 351853291)
28. Webster LR, Choi Y, Desai H, et al. Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008;9:425-432 (Pubitemid 351722516)
29. Smith MT, Buenaver LF. Electroencephalographic correlates of pain and sleep interactions in humans. In: Lavigne G, et al., eds. Sleep and Pain. Seattle, WA: IASP Press; 2007:189-191
30. Wittig RM, Zorick FJ, Blumer D, et al. Disturbed sleep in patients complaining of chronic pain. J Nerv Mental Dis 1982;170:429-431 (Pubitemid 12045403)
31. Wilson KG, Watson ST, Currie SR. Daily diary and ambulatory activity monitoring of sleep in patients with insomnia associated with chronic musculoskeletal pain. Pain 1998;75:75-84 (Pubitemid 28254858)
32. Marin R, Cyhan T, Miklos W. Sleep disturbance in patients with chronic low back pain. Am J Phys Med Rehabil 2006;85:430-435 (Pubitemid 43739327)
33. Zelman DC, Brandenburg NA, Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 2006;22:681-685 (Pubitemid 44434950)
34. Sloan EP, Maunder RG, Hunter JJ, et al. Insecure attachment is associated with the alpha-EEG anomaly during sleep. Biopsychosoc Med 2008;2:24-30
35. Drewes AM, Svendsen L, Jorgsen S. Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/ wake interactions. Br J Rheumatol 1998;37:71-81 (Pubitemid 28371823)
36. Buysse DJ, Reynolds 3rd CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213
37. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-545
38. Zallek SN, Redenius R, Fisk H, et al. A single question as a sleepiness screening tool. J Clin Sleep Med 2008;4:143-148 (Pubitemid 352038655)
39. Argoff CE. The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain 2007;23:15-22
40. Caldwell JR, Rapoport RJ, Davis JC, et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderateto- severe osteoarthritis pain: results from a randomized, placebo- controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002;23:278-291 (Pubitemid 34462941)
41. Matsumoto AK, Babul N, Ahdieh H. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial. Pain Med 2005;6:357-366 (Pubitemid 41727333)
42. Nicholson B, Ross E, Weil A, et al. Treatment of chronic moderate- to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules. Curr Med Res Opin 2006;22:539-550
43. Rauck RL, Bookbinder SA, Bunker TR, et al. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. J Opioid Manage 2006;2:325-8, 331-333
44. Rauck RL, Bookbinder SA, Bunker TR, et al. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. J Opioid Manage 2006;2:155-166
45. Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med 2000;160:853-860 (Pubitemid 30165247)
46. Adams EH, Chwiecko P, Ace-Wagoner Y, et al. A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions - the ACCPT Study. Pain Pract 2006;6:254-264 (Pubitemid 44920925)
47. Nicholson B, Ross E, Sasaki J, et al. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled- release oxycodone HCl in moderate to severe nonmalignant pain. Curr Med Res Opin 2006;22:1503-1514 (Pubitemid 44297429)
48. Kivitz A, Ma C, Ahdieh H, et al. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 2006;28:352-364 (Pubitemid 43783436)
49. Hale ME, Dvergsten C, Gimbel J. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. J Pain 2005;6:21-28 (Pubitemid 40051998)
50. Watson CP, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003;105:71-78 (Pubitemid 37162475)
51. Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999;26:862-869 (Pubitemid 29195674)
52. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003;60:927-934 (Pubitemid 36348923)
53. Markenson JA, Croft J, Zhang PG, et al. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 2005;21:524-535 (Pubitemid 41527742)
54. Gammaitoni AR, Galer BS, Lacouture P, et al. Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back pain. Pain Med 2003;4:21-30 (Pubitemid 37161326)
55. Walker JM, Farney RJ, Rhondeau SM, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007;3:455-461 (Pubitemid 47378247)
56. Haddox JD, Joranson DE, Angarola RT, et al. The use of opioids for the treatment of chronic pain: a consensus from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997;13:6-8
57. Wang D, Teichtahl H. Opioids, sleep architecture and sleep-disordered breathing. Sleep Med Rev 2007;11:35-46 (Pubitemid 46096783)
58. Wang D, Teichtahl H, Drummer O, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest 2005; 128:1348-1356 (Pubitemid 41324417)
59. Tashjian RZ, Banerjee R, Bradley MP, et al. Zolpidem reduces postoperative pain, fatigue, and narcotic consumption following knee arthroscopy: a prospective randomized placebo-controlled double-blinded study. J Knee Surg 2006;19:105-111
60. Walsh JK, Muehlbach MJ, Lauter SA, et al. Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis. J Rheumatol 1996;23:245-252 (Pubitemid 26079222)
61. Moldofsky H, Lue FA, Mously C, et al. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol 1996; 23:529-533 (Pubitemid 26101596)
62. Gronblad M, Nykannen J, Konttinen Y, et al. Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial. Clin Rheumatol 1993;12:186-191 (Pubitemid 23246750)
63. Drewes AM, Andreasen A, Jennum P, et al. Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol 1991;20:288-293
64. Lieberman JA. Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care. J Clin Psychiatry 2007;9:25-31 (Pubitemid 46280275)
65. Roth TJ. Measuring treatment efficacy in insomnia. J Clin Psychiatry 2004;65(Suppl 8):8-12